Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents

Clinical Pharmacology and Therapeutics
E IatsimirskaiaT Koudriakova

Abstract

Biotransformation of rifabutin, an antibiotic used for treatment of tuberculosis in patients infected with the human immunodeficiency virus (HIV), and its interactions with some macrolide and antifungal agents were studied in human intestinal and liver microsomes. Both liver and enterocyte microsomes metabolized rifabutin to 25-O-deacetylrifabutin, 27-O-demethylrifabutin, and 20-, 31-, and 32-hydroxyrifabutin. The same products (except 25-O-deacetylrifabutin) were formed by microsomes from lymphoblastoid cells that contained expressed CYP3A4. The apparent Michaelis-Menten constant (Km); approximately 10 to 12 mumol/L) and maximal velocity (Vmax; approximately 100 pmol/min/mg of protein) values for CYP-mediated metabolism were similar in liver and enterocyte microsomes. Deacetylation of rifabutin (Km approximately 16 to 20 mumol/L and Vmax approximately 50 to 100 pmol/min/mg of protein) was catalyzed by microsomal cholinesterase. Clarithromycin, ketoconazole, and fluconazole inhibited CYP-mediated metabolism of rifabutin in enterocyte microsomes equally or more potently than in liver microsomes but had no effect on cholinesterase activity. Azithromycin did not inhibit in vitro metabolism of rifabutin. This study provides evidenc...Continue Reading

References

Feb 1, 1992·The British Journal of Dermatology·D J BackS M Abel
Nov 1, 1992·Journal of Clinical Pharmacology·S Y ChuC Craft
Dec 1, 1990·The Journal of Antimicrobial Chemotherapy·R BattagliaM Strolin Benedetti
Nov 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M Strolin BenedettiM Repetto
Jul 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G CocchiaraA Vigevani
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·M H SkinnerT F Blaschke
Apr 1, 1989·British Journal of Clinical Pharmacology·S K GuptaM Rowland
Dec 1, 1985·The Journal of Antibiotics·A VigevaniG Franceschi
Jan 1, 1988·Clinical Pharmacokinetics·T K Daneshmend, D W Warnock
Jan 1, 1987·European Journal of Clinical Pharmacology·N R BadcockJ G Reid
Oct 1, 1987·The Journal of Clinical Investigation·P B WatkinsP S Guzelian
Sep 1, 1985·Clinical Pharmacokinetics·F M Williams
May 1, 1982·Archives of Surgery·E E Mason
May 5, 1994·The New England Journal of Medicine·P K NarangJ R Bianchine
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·C A Jamis-DowJ M Collins
Feb 1, 1993·Pharmacology & Therapeutics·U Christians, K F Sewing
Jan 1, 1993·Clinical Pharmacokinetics·D Debruyne, J P Ryckelynck
Nov 1, 1995·The Annals of Pharmacotherapy·A L Tseng, S L Walmsley
Mar 15, 1996·Annals of Internal Medicine·C B TrapnellJ P Lavelle
May 1, 1996·Clinical Pharmacology and Therapeutics·K E ThummelG R Wilkinson
Jul 1, 1996·Clinical Pharmacology and Therapeutics·M F PaineK E Thummel
Aug 1, 1953·The Biochemical Journal·M DIXON

❮ Previous
Next ❯

Citations

Sep 5, 2002·British Journal of Clinical Pharmacology·G J MoyleD A Hawkins
Oct 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marc WeinerUNKNOWN Tuberculosis Trials Consortium
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·R E PolkD S Stein
Jan 4, 2001·Drug Metabolism Reviews·S A WrightonP B Watkins
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Dec 21, 2007·Journal of Clinical Pharmacology·Kyoung-Ah KimJi-Young Park
Jul 2, 2005·Bioorganic & Medicinal Chemistry Letters·Yong-Hua WangLing Yang
Feb 18, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Guillaume BaneyxThierry Lavé
Oct 8, 1998·The Annals of Pharmacotherapy·B M Lomaestro, M A Piatek
Jan 3, 2001·Alimentary Pharmacology & Therapeutics·F CanducciA Gasbarrini
Nov 24, 1998·Journal of Clinical Pharmacology·M LeBelP K Narang
Aug 6, 1999·Journal of Clinical Pharmacology·G FouldsG Apseloff
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Hiroshi KomuraYuichi Sugiyama
Jul 4, 2001·Clinical Pharmacokinetics·W J BurmanC Peloquin
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Nov 23, 2006·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·M D LeeL Gong
Dec 2, 2011·Alimentary Pharmacology & Therapeutics·J P Gisbert, X Calvet
Aug 3, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·T MaeT Hidaka
Oct 26, 1999·The Pediatric Infectious Disease Journal·J D MarshallG L Kearns
Feb 9, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·H Manisha YapaAnton Pozniak
Apr 21, 2001·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C EmotoT Yokoi
Feb 22, 2012·Biopharmaceutics & Drug Disposition·Jun-ichi KusabaTetsuya Aiba
Oct 11, 2015·The Journal of Pharmacy and Pharmacology·Dave A MillerJames W McGinity
Feb 3, 2005·Biological & Pharmaceutical Bulletin·Tetsuya AibaYukiya Hashimoto
Apr 21, 2001·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C EmotoT Yokoi
Mar 19, 2014·Journal of Agricultural and Food Chemistry·Yong-Sang LeeJeong-Han Kim
Sep 14, 2007·Journal of Pharmaceutical Sciences·Hiroshi Komura, Masahiro Iwaki
Oct 2, 2021·Expert Opinion on Pharmacotherapy·Elias Xirouchakis, Sotirios D Georgopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.